1   Preface
2   Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Medical Specialty Bags Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Product
    6.1    Anesthesia Breathing Bags
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Blood Bags
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Sterile Packaging Bags
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Ostomy Collection Bags
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Enteral Feeding Bags
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Cadaver Bags
        6.6.1 Market Trends
        6.6.2 Market Forecast
    6.7    Continuous Ambulatory Peritoneal Dialysis (CAPD) Bags
        6.7.1 Market Trends
        6.7.2 Market Forecast
    6.8    Intravenous Fluid Bags
        6.8.1 Market Trends
        6.8.2 Market Forecast
    6.9    Others
        6.9.1 Market Trends
        6.9.2 Market Forecast
7   Market Breakup by End User
    7.1    Hospitals
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Ambulatory Surgical Centers
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Home Healthcare
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Others
        7.4.1 Market Trends
        7.4.2 Market Forecast
8   Market Breakup by Region
    8.1    North America
        8.1.1 United States
           8.1.1.1 Market Trends
           8.1.1.2 Market Forecast
        8.1.2 Canada
           8.1.2.1 Market Trends
           8.1.2.2 Market Forecast
    8.2    Asia-Pacific
        8.2.1 China
           8.2.1.1 Market Trends
           8.2.1.2 Market Forecast
        8.2.2 Japan
           8.2.2.1 Market Trends
           8.2.2.2 Market Forecast
        8.2.3 India
           8.2.3.1 Market Trends
           8.2.3.2 Market Forecast
        8.2.4 South Korea
           8.2.4.1 Market Trends
           8.2.4.2 Market Forecast
        8.2.5 Australia
           8.2.5.1 Market Trends
           8.2.5.2 Market Forecast
        8.2.6 Indonesia
           8.2.6.1 Market Trends
           8.2.6.2 Market Forecast
        8.2.7 Others
           8.2.7.1 Market Trends
           8.2.7.2 Market Forecast
    8.3    Europe
        8.3.1 Germany
           8.3.1.1 Market Trends
           8.3.1.2 Market Forecast
        8.3.2 France
           8.3.2.1 Market Trends
           8.3.2.2 Market Forecast
        8.3.3 United Kingdom
           8.3.3.1 Market Trends
           8.3.3.2 Market Forecast
        8.3.4 Italy
           8.3.4.1 Market Trends
           8.3.4.2 Market Forecast
        8.3.5 Spain
           8.3.5.1 Market Trends
           8.3.5.2 Market Forecast
        8.3.6 Russia
           8.3.6.1 Market Trends
           8.3.6.2 Market Forecast
        8.3.7 Others
           8.3.7.1 Market Trends
           8.3.7.2 Market Forecast
    8.4    Latin America
        8.4.1 Brazil
           8.4.1.1 Market Trends
           8.4.1.2 Market Forecast
        8.4.2 Mexico
           8.4.2.1 Market Trends
           8.4.2.2 Market Forecast
        8.4.3 Others
           8.4.3.1 Market Trends
           8.4.3.2 Market Forecast
    8.5    Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Breakup by Country
        8.5.3 Market Forecast
9   SWOT Analysis
    9.1    Overview
    9.2    Strengths
    9.3    Weaknesses
    9.4    Opportunities
    9.5    Threats
10  Value Chain Analysis
11  Porters Five Forces Analysis
    11.1    Overview
    11.2    Bargaining Power of Buyers
    11.3    Bargaining Power of Suppliers
    11.4    Degree of Competition
    11.5    Threat of New Entrants
    11.6    Threat of Substitutes
12  Price Analysis
13  Competitive Landscape
    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Ambu A/S
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio
           13.3.1.3 Financials
           13.3.1.4 SWOT Analysis
        13.3.2    B. Braun Melsungen AG
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
           13.3.2.3 SWOT Analysis
        13.3.3    Baxter International Inc.
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio
           13.3.3.3 Financials
           13.3.3.4 SWOT Analysis
        13.3.4    Becton Dickinson and Company
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio
           13.3.4.3 Financials
           13.3.4.4 SWOT Analysis
        13.3.5    Coloplast A/S
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio
           13.3.5.3 Financials
           13.3.5.4 SWOT Analysis
        13.3.6    ConvaTec Group PLC
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio
           13.3.6.3 Financials
        13.3.7    Hollister Incorporated
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio
           13.3.7.3 SWOT Analysis
        13.3.8    Macopharma
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio
        13.3.9    Medline Industries LP
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio
           13.3.9.3 SWOT Analysis
        13.3.10    Nolato AB
           13.3.10.1 Company Overview
           13.3.10.2 Product Portfolio
           13.3.10.3 Financials
        13.3.11    Pall Corporation (Danaher Corporation)
           13.3.11.1 Company Overview
           13.3.11.2 Product Portfolio
           13.3.11.3 SWOT Analysis
        13.3.12    SB-Kawasumi Laboratories Inc. (Sumitomo Bakelite Co. Ltd.)
           13.3.12.1 Company Overview
           13.3.12.2 Product Portfolio
        13.3.13    Terumo Corporation
           13.3.13.1 Company Overview
           13.3.13.2 Product Portfolio
           13.3.13.3 Financials
           13.3.13.4 SWOT Analysis
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer



 
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			